Skip to main content

Fecal Incontinence

Fecal incontinence (FI) is involuntary loss of solid or liquid stool; anal incontinence is the broader term that also includes involuntary flatus loss.[1][2] For the reconstructive urologist and urogynecologist, FI sits at the interface of posterior-compartment support, obstetric anal sphincter injury (OASIS), rectovaginal fistula, rectal prolapse, neuromodulation, and pelvic-floor rehabilitation. The goal is not to turn every pelvic surgeon into a colorectal specialist; it is to identify the mechanism, start low-risk treatment, and know when sphincter imaging, neuromodulation, sphincteroplasty, prolapse repair, or colorectal referral is the correct next step.

ACOG recommends nonsurgical treatment as initial management for women with FI except when rectovaginal fistula, rectal prolapse, or another surgically correctable lesion is present.[3]

Classification​

Classify FI by symptom pattern before ordering tests:[1][2]

PatternClinical meaningCommon mechanism
Urgency FILeakage preceded by a compelling need to defecateLoose stool, rectal hypersensitivity, reduced squeeze reserve, external anal sphincter weakness
Passive FILeakage without awarenessInternal anal sphincter weakness, impaired sensation, neuropathy, overflow
Mixed FIBoth urgency and passive leakageMultifactorial; common in older patients and after OASIS
Post-defecatory seepageSmall-volume leakage after an apparently complete bowel movementIncomplete evacuation, hemorrhoids, rectocele, stool trapping, impaired hygiene mechanics

Severity depends on frequency, stool consistency, volume, pad use, urgency, and quality-of-life impact. Use a structured scale when tracking response: Wexner / Cleveland Clinic Florida FI score, St Mark's score, or Fecal Incontinence Severity Index.

Epidemiology and Impact​

FI affects roughly 7-15% of community-dwelling adults depending on definition, age, and minimum frequency threshold; prevalence rises with age and institutionalization.[1][2][4] Underreporting is the rule. Patients often do not volunteer FI unless asked directly, especially when symptoms are intermittent or limited to staining and seepage.[1][5]

Key clinical patterns:

  • FI is often multifactorial; sphincter defects, loose stool, urgency, impaired sensation, incomplete evacuation, cognitive impairment, and mobility limitations commonly coexist.
  • Women have slightly higher reported prevalence than men, but the sex difference is smaller than clinicians often assume.[1]
  • Up to half of nursing-home residents have FI, where immobility, cognition, stool consistency, toileting access, and medications often dominate management.[1]
  • FI can be more socially disabling than urinary incontinence and is a driver of isolation, sexual avoidance, skin breakdown, caregiver burden, and institutionalization.[2]

Pathophysiology​

Continence depends on five interacting systems:[1][2][6]

SystemContinence roleFailure pattern
Internal anal sphincter (IAS)Resting tone; passive continencePassive leakage, seepage, soiling
External anal sphincter (EAS) + puborectalisVoluntary squeeze and anorectal angle controlUrgency leakage, inability to defer defecation
Rectal reservoirCapacity and complianceUrgency with low rectal volume, radiation/proctitis-related FI
Stool consistency / transitFormed stool is easier to retain than liquid stoolDiarrhea, bile-acid diarrhea, overflow around impaction
Neurologic and cognitive controlSensation, reflexes, mobility, toileting behaviorPassive FI, functional FI, neurogenic bowel

In prospective physiologic series, most patients have more than one abnormality. This is why a visible EAS defect on ultrasound does not automatically mean sphincteroplasty is the answer.

Etiology and Risk Factors​

Bowel disturbance​

Loose stool and urgency are often the most powerful modifiable drivers. Diarrhea, rectal urgency, frequent stools, fecal impaction with overflow, irritable bowel syndrome, inflammatory bowel disease, celiac disease, bile-acid diarrhea, metformin, magnesium, antibiotics, and laxative overuse should be addressed before procedural treatment.[1][2][7]

Obstetric and pelvic-floor injury​

OASIS is the signature urogynecologic risk factor. Clinically recognized third- or fourth-degree tears occur in a minority of vaginal deliveries, but occult sphincter defects are common on postpartum imaging.[3][4] FI may present decades after delivery, as aging, menopause, neuropathy, prolapse, obesity, and stool changes overwhelm a previously compensated sphincter complex.

Risk factors for obstetric sphincter injury include forceps delivery, prolonged second stage, large infant birth weight, occiput-posterior position, midline episiotomy, and operative vaginal delivery.[3][4]

Surgical, anatomic, and neurologic causes​

  • Anorectal surgery — fistulotomy, lateral internal sphincterotomy, hemorrhoidectomy, low anterior resection
  • Pelvic radiation — proctitis, poor rectal compliance, urgency, bleeding, fistula risk
  • Rectal prolapse / intussusception / rectocele — impaired evacuation and seepage
  • Rectovaginal fistula — stool or flatus through the vagina, not true sphincteric FI
  • Neurologic disease — diabetes neuropathy, stroke, dementia, spinal cord injury, multiple sclerosis, pudendal neuropathy
  • Functional impairment — mobility limitation, delayed toileting assistance, cognition, sedatives

Diagnosis and Evaluation​

Initial office evaluation​

ACOG and ASCRS both emphasize history, symptom characterization, and focused examination before routine ancillary testing.[3][4]

Ask directly:

  • Leakage type: solid, liquid, gas, seepage, mucus
  • Pattern: urgency vs passive vs post-defecatory seepage
  • Frequency, volume, pad use, skin breakdown, sexual impact, activity restriction
  • Stool form using the Bristol stool scale
  • Constipation, incomplete evacuation, manual splinting, diarrhea, urgency, rectal bleeding
  • Obstetric history: OASIS, forceps, episiotomy, large infant, delayed postpartum symptoms
  • Prior anorectal, vaginal, prolapse, mesh, fistula, or radiation history
  • Medications: metformin, magnesium, antibiotics, laxatives, stool softeners, cholinesterase inhibitors, caffeine, alcohol
  • Neurologic disease, cognition, mobility, toileting access, caregiver availability

Examination:

  • Inspection — perianal skin, soiling, hemorrhoids, scars, patulous anus, prolapse, fistula opening, perineal body deficiency
  • Digital rectal exam — resting tone, squeeze tone, puborectalis lift, rectal mass, fecal impaction, tenderness, stool consistency
  • Pelvic exam in women — posterior compartment prolapse, rectocele, perineorrhaphy deficiency, vaginal stool/flatus, atrophy/GSM, fistula suspicion
  • Neurologic screen — perineal sensation, anal wink, bulbocavernosus reflex when relevant, lower-extremity deficits

No routine laboratory panel is required. Use stool studies when infectious diarrhea is plausible. Colonoscopy is appropriate when FI accompanies change in bowel habits, rectal bleeding, melena, anemia, unexplained weight loss, abdominal pain, or age/risk-based colorectal cancer screening indications.[3][4]

When to order specialized testing​

Do not order every test for every patient. Testing should answer a management question: Is there a sphincter defect? Is evacuation impaired? Is sensation abnormal? Is prolapse/fistula driving symptoms? Is surgery being considered?[4][8][9]

TestUse
Anorectal manometryQuantifies resting/squeeze pressures, rectal sensation, cough reflex, and coordination; useful when symptoms persist or biofeedback/SNM/surgery is being planned
Endoanal ultrasoundBest routine test for IAS/EAS structural defects, especially OASIS or prior anorectal surgery
Pelvic MRIBetter for EAS atrophy, complex scarring, fistula mapping, levator injury, or when ultrasound is unavailable/equivocal
Balloon expulsion / defecographySuspected obstructed defecation, rectocele, intussusception, rectal prolapse, or seepage from incomplete evacuation
Pudendal nerve terminal motor latency / EMGLimited routine role; may help in selected neurogenic or complex surgical cases

Interpret imaging cautiously. Asymptomatic postpartum women can have sphincter defects, and symptomatic patients can have no visible defect. The test must be tied to a treatment decision.

Management​

First-line: conservative management​

Start with stool consistency and toileting mechanics. These interventions are low risk and often enough to avoid escalation.[3][4][5]

InterventionBest usePractical details
Bowel diaryBaseline and response trackingRecord stool form, urgency, leakage, meals, medications, and toileting schedule
Dietary trigger controlDiarrhea- or urgency-predominant FIIdentify caffeine, alcohol, artificial sweeteners, lactose, high-fat meals, spicy foods
Fiber supplementationLoose stool, seepage, variable stool formPsyllium is often preferred; titrate slowly to avoid bloating
LoperamideUrgency FI with loose stoolImproves stool consistency, urgency threshold, and resting tone; avoid constipation/impaction
Laxative adjustmentOverflow or constipation-associated FITreat impaction and incomplete evacuation before labeling as sphincter failure
Scheduled toiletingOlder adults, mobility impairment, predictable postprandial urgencyUse gastrocolic reflex after meals; coordinate caregiver access
Skin care / padsAny ongoing leakageBarrier creams, breathable pads, prompt cleansing; treat dermatitis early

Pelvic-floor physical therapy and biofeedback​

Pelvic-floor muscle training can strengthen the EAS and levator complex, improve coordination, and teach urge suppression. Biofeedback adds visual or auditory feedback from EMG or pressure sensors to isolate EAS contraction without abdominal substitution and to retrain rectal sensation.[3][5][10]

Best candidates:

  • Urgency FI with weak squeeze but preserved cognition and motivation
  • Passive or mixed FI with mild-to-moderate sphincter weakness
  • Postpartum or post-OASIS patients before considering delayed sphincter repair
  • Patients with dyssynergic defecation and seepage from incomplete evacuation

Less favorable candidates include severe dementia, severe rectal hyposensitivity, complete spinal cord injury, profound immobility, and patients who cannot practice between sessions.

Bulking agents​

Anal canal bulking agents may reduce FI episodes for several months and can be considered after conservative therapy fails, especially when a patient wants a lower-risk office or outpatient option.[3][4] Durability is limited, repeat treatment is common, and bulking does not correct major sphincter disruption, prolapse, diarrhea, or evacuation failure.

Sacral neuromodulation​

Sacral neuromodulation (SNM) is the most important procedural therapy for refractory FI and is FDA-approved for FI in the United States.[3][4] It uses an S3 tined lead and implantable pulse generator after a successful test phase, typically defined as at least 50% reduction in FI episodes.

Why it matters to WARWIKI: the same reconstructive teams that implant SNM for OAB, UUI, and non-obstructive retention often manage FI indications, device selection, MRI compatibility, lead placement, pocket revision, infection, and battery strategy.

Evidence and counseling:

  • Systematic review data show roughly 50-65% of patients maintain at least 50% FI episode reduction over medium- to long-term follow-up, with complete continence in a smaller subset.[3][11]
  • SNM can work in patients with sphincter defects or pudendal neuropathy; the test-stimulation response is the best predictor of success.[4][12]
  • Adverse events include pain, infection, lead migration, hematoma, loss of efficacy, battery replacement, pocket revision, and explant.[3][11]

Sphincteroplasty​

Overlapping sphincteroplasty may be considered for FI with a discrete EAS defect after failed conservative therapy, especially in delayed OASIS presentations.[3][4] The limiting reality is durability: short-term improvement is common, but results often deteriorate over time, and long-term sustained benefit may be present in only a minority of patients.[4][13]

Counseling points:

  • Sphincteroplasty repairs anatomy; it does not correct diarrhea, rectal hypersensitivity, neuropathy, poor compliance, cognitive impairment, or evacuation dysfunction.
  • Delayed postpartum FI is frequently multifactorial, even with a visible EAS defect.
  • SNM is often preferred for refractory FI even when a sphincter defect exists, particularly when the defect is not massive or when neuropathy/urgency physiology dominates.[12][13]

Correct the surgically correctable lesion​

FI from rectovaginal fistula, rectal prolapse, large symptomatic rectocele with stool trapping, or severe posterior-compartment/perineal body disruption should be managed as anatomy plus continence, not FI alone. These patients need pelvic-surgery expertise and, often, colorectal collaboration.

Special Populations​

Postpartum and delayed OASIS​

Ask about remote obstetric trauma even when delivery occurred decades earlier. A thin perineal body, gaping introitus, keyhole deformity, or poor squeeze should prompt consideration of endoanal ultrasound or MRI before posterior repair. FI counseling belongs in the same conversation as posterior colporrhaphy, perineorrhaphy, and rectovaginal fistula repair.

Older adults​

Treatment success often depends less on sphincter pressure and more on stool form, mobility, cognition, medication simplification, toileting access, skin care, and caregiver support.[14] Avoid creating constipation or impaction with aggressive loperamide.

Men​

Men underreport FI and should be asked directly. Common settings include post-anorectal surgery, diabetes neuropathy, pelvic radiation, neurologic disease, diarrhea, and rectal prolapse. The evaluation is similar, with emphasis on DRE, stool consistency, anorectal surgical history, radiation history, and neurologic risk.

Neurologic disease​

FI in spinal cord injury, multiple sclerosis, dementia, stroke, or diabetic neuropathy may require a bowel program rather than isolated sphincter treatment. Biofeedback requires cognition and practice capacity; SNM candidacy depends on neurologic diagnosis, intact peripheral pathways, MRI needs, and test response.

Follow-Up and Failure Patterns​

Track:

  • FI episodes per week
  • Stool consistency and urgency
  • Pad use and skin breakdown
  • Wexner / St Mark's score
  • Bowel diary response to fiber, loperamide, laxative changes, and scheduled toileting
  • Patient-prioritized goal: no solid stool leakage, less urgency, fewer pads, social confidence, sexual comfort, caregiver ease

If treatment fails, reassess the mechanism:

  • Persistent loose stool or medication-driven diarrhea
  • Overflow from constipation/impaction
  • Rectal prolapse, intussusception, or rectocele with trapping
  • Rectovaginal fistula rather than sphincteric FI
  • Unrecognized EAS/IAS defect or atrophy
  • Neurologic disease, cognition, or toileting access
  • Radiation proctitis or inflammatory bowel disease

See Also​

References​

1. Bharucha AE, Knowles CH, Mack I, et al. "Faecal Incontinence in Adults." Nat Rev Dis Primers. 2022;8(1):53. doi:10.1038/s41572-022-00381-7

2. Haylen BT, de Ridder D, Freeman RM, et al. "An International Urogynecological Association (IUGA) / International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction." Neurourol Urodyn. 2010;29(1):4-20. doi:10.1002/nau.20798

3. ACOG Practice Bulletin No. 210: "Fecal Incontinence." Obstet Gynecol. 2019;133(4):e260-e273. doi:10.1097/AOG.0000000000003187

4. Bordeianou LG, Thorsen AJ, Keller DS, et al. "The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Fecal Incontinence." Dis Colon Rectum. 2023;66(5):647-661. doi:10.1097/DCR.0000000000002776

5. Wald A, Bharucha AE, Limketkai B, et al. "ACG Clinical Guidelines: Management of Benign Anorectal Disorders." Am J Gastroenterol. 2021;116(10):1987-2008. doi:10.14309/ajg.0000000000001507

6. Rao SSC. "Pathophysiology of Adult Fecal Incontinence." Gastroenterology. 2004;126(1 Suppl 1):S14-S22. doi:10.1053/j.gastro.2003.10.013

7. Bharucha AE, Zinsmeister AR, Locke GR, et al. "Risk Factors for Fecal Incontinence: A Population-Based Study in Women." Am J Gastroenterol. 2006;101(6):1305-1312. doi:10.1111/j.1572-0241.2006.00553.x

8. Sbeit W, Khoury T, Mari A. "Diagnostic Approach to Faecal Incontinence: What Test and When to Perform?" World J Gastroenterol. 2021;27(15):1553-1562. doi:10.3748/wjg.v27.i15.1553

9. Rosier PFWM, Kuo HC, De Gennaro M, et al. "International Consultation on Incontinence 2016; Executive Summary: Urodynamic Testing." Neurourol Urodyn. 2019;38(2):545-552. doi:10.1002/nau.23903

10. Mazur-Bialy AI, Kolomanska-Bogucka D, Oplawski M, Tim S. "Physiotherapy for Prevention and Treatment of Fecal Incontinence in Women-Systematic Review of Methods." J Clin Med. 2020;9(10):3255. doi:10.3390/jcm9103255

11. Thaha MA, Abukar AA, Thin NN, Ramsanahie A, Knowles CH. "Sacral Nerve Stimulation for Faecal Incontinence and Constipation in Adults." Cochrane Database Syst Rev. 2015;(8):CD004464. doi:10.1002/14651858.CD004464.pub3

12. Emile SH, Wignakumar A, Horesh N, et al. "Efficacy of Sacral Neuromodulation in Treatment of Fecal Incontinence Associated With Anal Sphincter Defects: A Systematic Review and Meta-Analysis." World J Surg. 2026;50(1):48-57. doi:10.1002/wjs.70152

13. Rodrigues FG, Chadi SA, Cracco AJ, et al. "Faecal Incontinence in Patients With a Sphincter Defect: Comparison of Sphincteroplasty and Sacral Nerve Stimulation." Colorectal Dis. 2017;19(5):456-461. doi:10.1111/codi.13510

14. Wang XJ, Nguyen LAB. "'Functional' GI Conditions in the Older Adult: DGBIs and Beyond." Am J Gastroenterol. 2025;120(Suppl 10):S45-S55. doi:10.14309/ajg.0000000000003641.06